杭州九源基因生物医药股份有限公司(02566)于2026年2月10日发布翌日披露报表，披露当日回购285,200股H股，占回购前公司已发行股份（不包括库藏股）的约0.27024%。
本次回购于香港联交所进行，价格区间介于每股9.83港元至10.30港元之间，合计支付约2,870,506.048港元。根据2025年6月11日获通过的购回授权，公司剩余可回购股份数为10,909,678股。回购完成后，公司已发行股份总数维持在109,096,785股，其中流通股为105,248,985股，库藏股为3,847,800股。
公司确认已严格遵守相关上市规则及法律规定。公告由联席公司秘书黄秀签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.